Furosemide Dosing Guidelines for Adolescents with PSGN

Introduction to Furosemide Dosing

The American Academy of Pediatrics and nephrology guidelines recommend using pediatric dosing for adolescents with PSGN, starting with furosemide 0.5-2 mg/kg per dose (up to 6 times daily), with a maximum of 10 mg/kg/day, rather than the standard adult dose of 40 mg 1, 2, 3

At age 17, this patient falls within the pediatric dosing range, as guidelines for furosemide in children with edema and nephrotic conditions do not specify an upper age cutoff, and weight-based dosing is more appropriate for adolescents who may have variable body mass 1, 2, 3
The clinical presentation of PSGN with significant edema and decreased urine output requires aggressive diuresis, which is better achieved with weight-based dosing that can be titrated to response rather than a fixed adult dose 1, 3

Start with furosemide 0.5-1 mg/kg IV or oral per dose, administered up to 6 times daily based on the degree of edema and achieved diuresis, with a typical initial dose of 25-70 mg per dose for a 17-year-old weighing 50-70 kg 1, 2, 3
Increase by 1 mg/kg increments if adequate diuresis is not achieved, with an absolute maximum of 10 mg/kg/day for severe edema 1, 2, 3
Doses exceeding 6 mg/kg/day should not be continued for more than 1 week due to significant ototoxicity risk 1, 2, 3

Administer IV infusions over 5-30 minutes to minimize ototoxicity, and ensure the patient does not have marked hypovolemia before initiating therapy, as furosemide can worsen intravascular volume depletion 1, 2, 3

Before each dose, assess for intravascular volume status, and avoid furosemide if there is marked hypovolemia, hypotension, or anuria 1, 3, 5
During therapy, monitor fluid status and urine output, electrolytes, blood pressure, and renal function to detect potential complications 1, 2, 3

Do not exceed 6 mg/kg/day for more than 1 week to prevent permanent hearing loss from ototoxicity, and do not administer furosemide if the patient has marked hypovolemia or anuria 1, 2, 3, 5
Avoid rapid IV bolus administration, and always infuse over 5-30 minutes to reduce ototoxicity risk 1, 2, 3

PSGN typically presents with fluid overload and hypertension, making diuretic therapy appropriate, and the patient's refusal of indwelling Foley catheter makes accurate urine output monitoring more challenging, but this should not preclude diuretic therapy 1, 2, 3
If potassium-sparing diuretics are needed, amiloride is preferable to spironolactone in this setting 1, 3